Finance

Lists
Outlook: 31.2% bullish·6.2% bearish
Go to analysis
ALL:NYSE
Allstate Corp
USD 251,04
+0,44%
(+1,10) 1D
USD 251,04
0,00% (0,00)
After hours
Closed: 21 Okt., 16:00:10 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALL...
Open
USD 250,58
High
USD 252,05
Low
USD 247,89
Mkt. cap
63,48 mjd
Avg. vol.
2,30 m
Volume
1,62 m
Dividend
1,72%
Quarterly dividend
USD 1,08
Ex-dividend date
31 Aug. 2026
P/E ratio
5,01
52-wk high
USD 277,22
52-wk low
USD 188,08
EPS
USD 50,06
Beta
0,13
Shares outstanding
252,86 m
No. of employees
53 k
Open
USD 250,58
High
USD 252,05
Low
USD 247,89
Mkt. cap
63,48 mjd
Avg. vol.
2,30 m
Volume
1,62 m
Dividend
1,72%
Quarterly dividend
USD 1,08
Ex-dividend date
31 Aug. 2026
P/E ratio
5,01
52-wk high
USD 277,22
52-wk low
USD 188,08
EPS
USD 50,06
Beta
0,13
Shares outstanding
252,86 m
No. of employees
53 k
News stories
From web sources and news partners
Profile
The Allstate Corporation is an American insurance company, headquartered in Glenview, Illinois since 2022. Founded in 1931 as part of Sears, Roebuck and Co., it was spun off in 1993, but was still partially owned by Sears until it became an independent company completely in June 1995. The company also has personal line insurance operations in Canada. With 2018 revenues of $39.8 billion, Allstate ranked 79th in the 2019 Fortune 500 list of the largest United States corporations by total revenue. Its advertising campaign, in use since 1950, asks, "Are you in good hands?", and the logo portrays a pair of human hands. Wikipedia
About Allstate Corp
CEOThomas J. Wilson
Employees53,2 k
Founded17 Apr. 1931
HeadquartersNorthfield Township, Illinois, Verenigde State van Amerika
Sector-
Analyst ratings
Based on 20 analysts giving stock ratings to ALL in the past 3 months
Buy
Buy
9
Hold
8
Sell
3
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for ALL in the last 3 months.
Highest
Current USD 251,04
USD 340,00 (+35,44%)
Average
USD 268,42 (+6,92%)
Lowest
USD 215,00 (-14,36%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brian Meredith
UBS
Hold
Reiterated
USD 275,00
+9,5%
10/20/2026
Bob Huang
Morgan Stanley
Hold
Reiterated
USD 240,00
-4,4%
10/16/2026
Elyse Greenspan
Wells Fargo
Hold
Reiterated
USD 236,00
-6%
10/16/2026
Meyer Shields
KBW
Sell
Maintained
USD 232,00
-7,6%
10/16/2026
Joshua Shanker
Bank of America Securities
Buy
Maintained
USD 340,00
+35,4%
10/12/2026
Yaron Kinar
Mizuho Securities
Buy
Maintained
USD 295,00
+17,5%
10/07/2026
Vikram Gandhi
HSBC
Buy
Upgraded
USD 266,00
+6%
10/07/2026
Alex Scott
Barclays
Sell
Maintained
USD 221,00
-12%
10/07/2026
Robert Cox CFA
Goldman Sachs
Hold
Maintained
USD 250,00
-0,4%
10/05/2026
Matthew Heimermann
Citi
Sell
Maintained
USD 215,00
-14,4%
10/05/2026
Paul Newsome
Piper Sandler
Buy
Maintained
USD 300,00
+19,5%
09/28/2026
David Motemaden
Evercore ISI
Hold
Maintained
USD 262,00
+4,4%
09/21/2026
Kevin Heal
Argus Research
Hold
Downgraded
USD 238,00
-5,2%
08/27/2026
Michael Zaremski
BMO Capital
Buy
Reiterated
USD 284,00
+13,1%
08/13/2026
Gregory Peters
Raymond James
Buy
Reiterated
USD 315,00
+25,5%
08/11/2026
Pablo Singzon
J.P. Morgan
Buy
Maintained
USD 292,00
+16,3%
08/11/2026
Mikhail Paramonov
Freedom Capital Markets
Buy
Upgraded
USD 297,00
+18,3%
08/07/2026
Adam Klauber
William Blair
Hold
Maintained
-
-
08/06/2026
Ryan Tunis
Cantor Fitzgerald
Hold
Maintained
USD 242,00
-3,6%
08/05/2026
Harry Fong
Roth MKM
Buy
Maintained
USD 300,00
+19,5%
08/06/2026
Jimmy Bhullar
J.P. Morgan
Buy
Maintained
USD 282,00
+12,3%
07/14/2026
Andrew Andersen
Jefferies
Buy
Maintained
USD 250,00
-0,4%
05/01/2026
Andrew Kligerman
TD Cowen
Hold
Maintained
-
-
04/02/2026
Last report
06 Aug. 2026
Fiscal period
Q2 2026
USD 8,99 / USD 6,07
+48,03%beat
Revenue / Est. (USD)
18,60 mjd / 17,30 mjd
+7,46%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
17,26 mjd
17,34 mjd
16,94 mjd
18,60 mjd
Cost of goods sold
10,82 mjd
9,93 mjd
11,44 mjd
12,14 mjd
Cost of revenue
10,82 mjd
9,93 mjd
11,44 mjd
12,14 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,16 mjd
2,33 mjd
2,24 mjd
2,17 mjd
Operating expense
2,22 mjd
2,38 mjd
2,29 mjd
2,22 mjd
Total operating expenses
13,04 mjd
12,31 mjd
13,73 mjd
14,35 mjd
Operating income
4,22 mjd
5,03 mjd
3,21 mjd
4,24 mjd
Other non operating income
-
-
-
-
EBT including unusual items
4,82 mjd
4,92 mjd
3,11 mjd
4,14 mjd
EBT excluding unusual items
4,12 mjd
4,94 mjd
3,11 mjd
4,15 mjd
Income tax expense
1,08 mjd
1,09 mjd
650,00 m
871,00 m
Effective tax rate
22,31%
22,14%
20,91%
21,03%
Other operating expenses
-
-
-
-
Net income
3,75 mjd
3,83 mjd
2,46 mjd
3,27 mjd
Net profit margin
21,71%
22,09%
14,50%
17,59%
Earnings per share
11,17
14,31
10,65
8,99
Interest and investment income
-
-
-
-
Interest expense
-101,00 m
-98,00 m
-98,00 m
-96,00 m
Net interest expenses
-101,00 m
-98,00 m
-98,00 m
-96,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
4,33 mjd
5,14 mjd
3,31 mjd
4,33 mjd
Gain or loss from assets sale
-714,00 m
3,00 m
-
3,00 m
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme